Alaunos Therapeutics Inc

Research Alaunos Therapeutics Inc (TCRT) on Bullrun: market cap USD 5.79M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTCRT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.79M
• Financial periodFY2025
• RevenueUSD 5.00K
• Revenue growth-50.0%
• Net income-USD 4.18M
• Free cash flow-USD 2.97M

Valuation Snapshot

latest market cap is USD 5.79M.

About Alaunos Therapeutics Inc

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.

Frequently asked questions

What is Alaunos Therapeutics Inc's market cap?

Alaunos Therapeutics Inc's market capitalization is USD 5.79M.

What does Alaunos Therapeutics Inc do?

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders.